Table 3: Blood parameter variations on the basis of different treatments.

CNVBRAPLYC

ΔTriglycerides (mmol/l)0.64 ± 144−10.74 ± 1.47−8.01 ± 1.89−8.15 ± 1.64<00001
ΔTotal cholesterol (mmol/l)1.28 ± 0.4−6.84 ± 0.77−5.51 ± 0.91−4.21 ± 1.07<0.0001
ΔLDL cholesterol (mmol/l)1.92 ± 1.62−5.06 ± 0.81−3.46 ± 0.98−4.2 ± 0.91<0.0001
ΔHDL cholesterol (mmol/l)0.12 ± 0.192.68 ± 0.251.4 ± 0.470.91 ± 1.80<0.0001
ΔGlycaemia (mmol/l)−0.2 ± 2.75−9.0 ± 1.58−1.5 ± 1.96−3.0 ± 1.83<0.0001
ΔsGOT (U/l)0.38 ± 0.78−2.52 ± 0.98−2.15 ± 0.56−1.66 ± 0.97<0.0001
ΔsGPT (U/l)1.58 ± 1.13−3.66 ± 0.88−1.9 ± 0.89−0.89 ± 0.80<0.0001
ΔTotal bilirubin (mmol/l)−0.0180 ± 0.15−0.16 ± 0.15−0.05 ± 0.37−0.52 ± 0.040.075
ΔCreatinin (mmol/l)0016 ± 0.07−0.16 ± 0.140.15 ± 0.13−0.15 ± 0.120.082

Δ: differences measured between posttreatment and baseline; LDL: low-density lipoprotein; HDL: high-density lipoprotein; sGOT: serum glutamic oxaloacetic transaminase; sGPT: serum glutamic pyruvic transaminase. VB versus CN (); VB versus RAP (); VB versus LYC (); VB versus RAP (); VB versus RAP (). RAP versus CN (); RAP versus LYC (); RAP versus LYC (). LYC versus CN (); LYC versus CN (); LYC versus CN ().